Further references used to develop this protocol:
Madanikia, S. A., A. Bergner, X. Ye, et al. 2012. "Increased risk of breast cancer in women with NF1." Am J Med Genet A 158A(12):3056-3060.
Wang, X., A. M. Levin, S. E. Smolinski, et al. 2012. "Breast cancer and other neoplasms in women with neurofibromatosis type 1: a retrospective review of cases in the Detroit metropolitan area." Am J Med Genet A 158A(12):3061-3064.
Riccardi, V. M. 1981. "Von Recklinghausen neurofibromatosis." N Engl J Med 305(27):1617-1627.
Bausch, B., W. Borozdin and H. P. Neumann. 2006. "Clinical and genetic characteristics of patients with neurofibromatosis type 1 and pheochromocytoma." N Engl J Med 354(25):2729-2731.
Ghrist, T. D. 1963. "Gastrointestinal Involvement in Neurofibromatosis." Arch Intern Med 112:357-362.
Side, L., B. Taylor, M. Cayouette, et al. 1997. "Homozygous inactivation of the NF1 gene in bone marrow cells from children with neurofibromatosis type 1 and malignant myeloid disorders." N Engl J Med 336(24):1713-1720.
Walker, L., D. Thompson, D. Easton, et al. 2006. "A prospective study of neurofibromatosis type 1 cancer incidence in the UK." Br J Cancer 95(2):233-238
Evans, D. G., C. O'Hara, A. Wilding, et al. 2011. "Mortality in neurofibromatosis 1: in North West England: an assessment of actuarial survival in a region of the UK since 1989." Eur J Hum Genet 19(11):1187-1191.
Rasmussen, S. A., Q. Yang and J. M. Friedman. 2001. "Mortality in neurofibromatosis 1: an analysis using U.S. death certificates." Am J Hum Genet 68(5):1110-1118.
Ferner, R. E., S. M. Huson, N. Thomas, et al. 2007. "Guidelines for the diagnosis and management of individuals with neurofibromatosis 1." J Med Genet 44(2):81-88.
Huson, S. M., P. S. Harper and D. A. Compston. 1988. "Von Recklinghausen neurofibromatosis. A clinical and population study in south-east Wales." Brain 111 ( Pt 6):1355-1381
Hersh, J. H. 2008. "Health supervision for children with neurofibromatosis." Pediatrics 121(3):633-642.
Williams, V. C., J. Lucas, M. A. Babcock, et al. 2009. "Neurofibromatosis type 1 revisited." Pediatrics 123(1):124-133.
King, A., R. Listernick, J. Charrow, et al. 2003. "Optic pathway gliomas in neurofibromatosis type 1: the effect of presenting symptoms on outcome." Am J Med Genet A 122A(2):95-99
Sung, L., J. R. Anderson, C. Arndt, et al. 2004. "Neurofibromatosis in children with Rhabdomyosarcoma: a report from the Intergroup Rhabdomyosarcoma study IV." J Pediatr 144(5):666-668
Zoller, M. E., B. Rembeck, A. Oden, et al. 1997. "Malignant and benign tumors in patients with neurofibromatosis type 1 in a defined Swedish population." Cancer 79(11):2125-2131.
DeBella K, Szudek J, Friedman JM. Use of the national institutes of health criteria for diagnosis of neurofibromatosis 1 in children. Pediatrics. 2000;105(3 Pt 1):608-14
Side LE, Emanuel PD,Taylor B, Franklin J, Thompson P, Castleberry RP, Shannon KM. Mutations of the NF1 gene in children with juvenile myelomonocytic leukemia without clinicals evidence of neurofibromatosis, type 1. Blood. 1998;92(1):267-72
Caen S, Cassiman C, Legius E, Casteels I. Comparative study of the ophthalmological examinations in neurofibromatosis type 1. Proposal for a new screening algorithm. Eur J Paediatr Neurol. 2015;19(4):415-22
|